Financial Summary
(ARRY) $46.57 (%)
-
SymbolARRYPrice46.57$Beta1.444318Volume Avrg.3000949Market Cap9243679300Last Div0Range12.56-25.05Changes17.69Changes PercentageExchangeNASDAQ Global MarketIndustryBiotechnologyCeoRon SquarerSectorHealthcare
Stock Search
About company
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Income Statement
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 260174.00 | 265595.00 | 229234.00 | 215639.00 | 233715.00 | 182795.00 | 17091.00 | 156508.00 | 108249.00 | 65225.00 | 42905.00 |
| Cost of revenues | 161782.00 | 163756.00 | 141048.00 | 131376.00 | 140089.00 | 112258.00 | 106606.00 | 87846.00 | 64431.00 | 39541.00 | 25683.00 |
| Gross profit | 98392.00 | 101839.00 | 88186.00 | 84263.00 | 93626.00 | 70537.00 | 64304.00 | 68662.00 | 43818.00 | 25684.00 | 17222.00 |
| Operating expensess | 34462.00 | 30941.00 | 26842.00 | 24239.00 | 22396.00 | 18034.00 | 15305.00 | 13421.00 | 10028.00 | 7299.00 | 5482.00 |
| Operating incomes | 6393.00 | 70898.00 | 61344.00 | 60024.00 | 7123.00 | 52503.00 | 48999.00 | 55241.00 | 3379.00 | 18385.00 | 1174.00 |
| Interest expense | 3576.00 | 324.00 | 2323.00 | 1456.00 | 733.00 | 384.00 | 136.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income tax expenses | 10481.00 | 13372.00 | 15738.00 | 15685.00 | 19121.00 | 13973.00 | 13118.00 | 1403.00 | 8283.00 | 4527.00 | 3831.00 |
| Earnings before taxs | 65737.00 | 72903.00 | 64089.00 | 61372.00 | 72515.00 | 53483.00 | 50155.00 | 55763.00 | 34205.00 | 1854.00 | 12066.00 |
| Net income | 55256.00 | 59531.00 | 48351.00 | 45687.00 | 53394.00 | 3951.00 | 37037.00 | 41733.00 | 25922.00 | 14013.00 | 8235.00 |
| Earnings per share basics | 11.97 | 12.01 | 9.27 | 8.35 | 9.28 | 6.49 | 40.03 | 44.64 | 28.05 | 15.41 | 1.317 |
| Earnings per share diluteds | 11.89 | 11.91 | 9.21 | 8.31 | 9.22 | 6.45 | 39.75 | 44.15 | 27.68 | 15.15 | 1.297 |
| Dividend per shares | 3.04 | 2.74 | 2.43 | 2.21 | 2 | 1.82 | 11.34 | 2.63 | 0 | 0 | 0 |
| Gross margins | 0.38 | 0.38 | 0.38 | 0.39 | 0.4 | 0.39 | 0.38 | 0.44 | 0.4 | 0.39 | 0.4 |
| EBIT margins | 0.25 | 0.27 | 0.27 | 0.28 | 0.3 | 0.29 | 0.29 | 0.35 | 0.31 | 0.28 | 0.28 |
| Profit margins | 0.21 | 0.22 | 0.21 | 0.21 | 0.23 | 0.22 | 0.22 | 0.27 | 0.24 | 0.21 | 0.19 |
| EBITDA | 76477.00 | 81801.00 | 71501.00 | 70529.00 | 82487.00 | 60449.00 | 55756.00 | 58518.00 | 35604.00 | 19412.00 | 128.00 |
| EBIT | 6393.00 | 70898.00 | 61344.00 | 60024.00 | 7123.00 | 52503.00 | 48999.00 | 55241.00 | 3379.00 | 18385.00 | 12066.00 |
| Earnings Before Tax Margins | 0.25 | 0.27 | 0.28 | 0.28 | 0.31 | 0.29 | 0.29 | 0.36 | 0.32 | 0.28 | 0.28 |
| Net Profit Margins | 0.21 | 0.22 | 0.21 | 0.21 | 0.23 | 0.22 | 0.22 | 0.27 | 0.24 | 0.21 | 0.19 |